PCM
EIDX

Prelude Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Prelude Capital Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,622
Closed -$3.37M – 1516
2020
Q4 		$3.37M Buy
+25,622
New +$3.37M 0.09% 61